Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Acute-On-Chronic Liver Failure (ACLF)

methoxyhydroxyphenylglycol has been researched along with Acute-On-Chronic Liver Failure (ACLF) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aguilar, F; Albillos, A; Alessandria, C; Angeli, P; Arroyo, V; Bañares, R; Berg, T; Bernardi, M; Bruns, T; Caraceni, P; Castelli, FA; Claria, J; de la Peña-Ramirez, C; Diaz, JM; Domenicali, M; Fenaille, F; Fernández, J; Gambino, CG; Genesca, J; Gerbes, AL; Giovo, I; Gu, W; Gustot, T; Jalan, R; Jansen, C; Jiménez, C; Junot, C; Laleman, W; Lozano, JJ; Martin, PI; Merli, M; Mookerjee, R; Moreau, R; Papp, M; Piano, S; Presa, J; Putignano, A; Saliba, F; Sánchez-Garrido, C; Sierra, P; Trautwein, C; Trebicka, J; Uschner, FE; Vargas, V; Weiss, E; Wendon, JA; Zaccherini, G; Zeuzem, S; Zipprich, A1

Other Studies

1 other study(ies) available for methoxyhydroxyphenylglycol and Acute-On-Chronic Liver Failure (ACLF)

ArticleYear
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
    Gut, 2023, Volume: 72, Issue:8

    Topics: Acute-On-Chronic Liver Failure; Humans; Inflammation; Liver Cirrhosis; Metabolomics; Methoxyhydroxyphenylglycol; Mitochondria; Prognosis; Prospective Studies

2023